Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Dec 1, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 13
- +1 vs. Q2 2023
- Portfolio value
- $458.4M
- +$69.2M (+17.8%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GLDSPDR Gold Trust | ETF | 1,062,500 | $182.2M | 39.7% | +507,500+91.4% | Added | History |
| iShares MSCI India ETF46429B598 | ETF | 2,425,144 | $107.2M | 23.4% | 00.0% | Unchanged | – |
| SPYSPDR S&P 500 ETF Trust | ETF | 246,250 | $105.3M | 23.0% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,627,643 | $16.1M | 3.5% | +82,401+3.2% | Added | History |
| RAPTRAPT Therapeutics, Inc. | COM | 657,899 | $10.9M | 2.4% | +86,666+15.2% | Added | History |
| MEHCQChrome Holding Co. | CLASS A COM | 10,243,122 | $10.0M | 2.2% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 1,307,858 | $8.47M | 1.8% | +326,964+33.3% | Added | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,573,761 | $7.87M | 1.7% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 989,410 | $5.99M | 1.3% | +241,860+32.4% | Added | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,015,705 | $2.59M | 0.6% | +100,000+10.9% | Added | History |
| NGMNGM Biopharmaceuticals Inc | COM | 992,168 | $1.06M | 0.2% | +245,494+32.9% | Added | History |
| SRZNSurrozen, Inc. | COM | 1,315,463 | $644.6K | 0.1% | +512,500+63.8% | Added | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 170,833 | $7.02K | <0.1% | +170,833 | New | – |